Pierre A. MORGON, PharmD, LL.M, MBA - CEO - Board Chair - INED - Mentor - Advisor

Dr. Pierre A. Morgon has extensive work experience in the pharmaceutical and biotech industry. Dr Pierre A. currently serves as the Executive Vice President of Portfolio Strategy & Supranational Affairs and Managing Director Europe at CanSino Biologics Inc. Since 2022, they have also been an Independent Non-Executive Director at Limula. Moreover, Dr. Morgon has held various leadership positions, including Chairman of the Board at Kupando GmbH, Amoéba, MYCB1 Group B.V., and Health Technology Holdings, and Independent Non-Executive Director and Executive Chairman of Quantoom Biosciences at UNIVERCELLS. Dr Pierre A. has also served as an Independent Non-Executive Director at Vaccitech, an Expert, Mentor, and Judge at MassChallenge Switzerland, and the Chief Executive Officer & Founder of MRGN Advisors. In their role at MRGN Advisors, Dr. Morgon provided strategic advisory services to companies in the pharma, vaccines, med tech, and healthcare IT sectors, advising on areas such as portfolio strategy, commercial development, partnering, and investment advisory.

Dr Pierre A. Morgon, PharmD, LL.M, MBA has an extensive educational background. Dr Pierre A. began their education by earning a Doctorate of Pharmacy, Magna cum Laude, from Université Claude Bernard Lyon 1 in 1985. Following this, they pursued a Master of Advances Studies in Business and Economic Law, cum Laude, from Université Jean Moulin (Lyon III) in 1986.

In 1987, Dr Pierre A. Morgon enrolled in ESSEC Business School, where they obtained a Master in Marketing Management in 1988. Dr Pierre A. continued their education in the field of business administration and management by participating in the Young Managers Program at INSEAD in 1993.

Dr Pierre A. Morgon continued to broaden their knowledge and expertise in business administration by completing the Breakthrough Program for Senior Executives at IMD in 2001. In 2003, they enrolled in the Senior Executive Program CEDEP at INSEAD, further enhancing their skills in business administration and management.

Overall, Dr Pierre A. Morgon's education history demonstrates their commitment to continuous learning and acquiring expertise in both pharmaceutical science and various aspects of business administration.